KOO vs. INS, RENX, COG, INHC, FDBK, IQAI, TRLS, DVRG, SENS, and EMIS
Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.
Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.
In the previous week, Kooth had 2 more articles in the media than Instem. MarketBeat recorded 2 mentions for Kooth and 0 mentions for Instem. Instem's average media sentiment score of 0.40 beat Kooth's score of -0.09 indicating that Instem is being referred to more favorably in the news media.
80.0% of Kooth shares are held by institutional investors. Comparatively, 65.9% of Instem shares are held by institutional investors. 11.3% of Kooth shares are held by insiders. Comparatively, 30.0% of Instem shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Instem has a net margin of 5.50% compared to Kooth's net margin of -0.51%. Instem's return on equity of 6.35% beat Kooth's return on equity.
Kooth presently has a consensus target price of GBX 585, suggesting a potential upside of 82.81%. Given Kooth's higher probable upside, research analysts clearly believe Kooth is more favorable than Instem.
Instem has higher revenue and earnings than Kooth.
Kooth has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500.
Instem received 85 more outperform votes than Kooth when rated by MarketBeat users. However, 88.89% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.
Summary
Instem beats Kooth on 8 of the 15 factors compared between the two stocks.
Get Kooth News Delivered to You Automatically
Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
